Importer of Controlled Substances Application: Fisher Clinical Services, Inc., 69070 [2021-26364]
Download as PDF
<![CDATA[
69070
Federal Register / Vol. 86, No. 231 / Monday, December 6, 2021 / Notices
Commission’s statement on adequacy,
and any individual Commissioner’s
statements will be available from the
Office of the Secretary and at the
Commission’s website.
Authority: These reviews are being
conducted under authority of title VII of
the Tariff Act of 1930; this notice is
published pursuant to § 207.62 of the
Commission’s rules.
By order of the Commission.
Issued: November 30, 2021.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2021–26341 Filed 12–3–21; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–935]
Importer of Controlled Substances
Application: Johnson Matthey Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Johnson Matthey Inc., has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 5, 2022. Such persons
may also file a written request for a
hearing on the application on or before
January 5, 2022.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on November 2, 2021,
Johnson Matthey Inc., 2003 Nolte Drive,
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:32 Dec 03, 2021
Jkt 256001
West Deptford, New Jersey 08066–0727,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
Controlled substance
Coca Leaves .............................
Thebaine ...................................
Opium, raw ...............................
Noroxymorphone ......................
Poppy Straw Concentrate .........
Fentanyl ....................................
Drug
code
Schedule
9040
9333
9600
9668
9670
9801
II
II
II
II
II
II
The company plans to import Coca
Leaves (9040), Opium raw (9600) and
Poppy Straw Concentrate (9670) in
order to bulk manufacture Active
Pharmaceutical Ingredients (API) for
distribution to its customers. The
company plans to also import Thebaine
(9333), Noroxymorphone (9668) and
Fentanyl (9801) to use as analytical
reference standards, both internally and
to be sold to their customers to support
testing of Johnson Matthey Inc.’s API’s
only.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of the Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–26361 Filed 12–3–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–936]
Importer of Controlled Substances
Application: Fisher Clinical Services,
Inc.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on August 25, 2021, Fisher
Clinical Services, Inc., 700A–C Nestle
Way, Breinigsville, Pennsylvania
18031–1522, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
ADDRESSES:
Controlled substance
Marihuana Extract .....................
Psilocybin ..................................
Methylphenidate ........................
Levorphanol ..............................
Noroxymorphone ......................
Tapentadol ................................
Drug
code
Schedule
7350
7437
1724
9220
9668
9780
I
I
II
II
II
II
The company plans to import the
listed controlled substances for use in
clinical trials only. No other activity for
these drug codes is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
Brian S. Besser,
Acting Assistant Administrator.
Fisher Clinical Services, Inc.,
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 5, 2022. Such persons
may also file a written request for a
hearing on the application on or before
January 5, 2022.
BILLING CODE 4410–09–P
AGENCY:
SUMMARY:
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
[FR Doc. 2021–26364 Filed 12–3–21; 8:45 am]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–934]
Bulk Manufacturer of Controlled
Substances Application: Kinetochem
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
E:\FR\FM\06DEN1.SGM
06DEN1
]]>Agencies
[Federal Register Volume 86, Number 231 (Monday, December 6, 2021)]
[Notices]
[Page 69070]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26364]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-936]
Importer of Controlled Substances Application: Fisher Clinical
Services, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Fisher Clinical Services, Inc., has applied to be registered
as an importer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before January 5, 2022.
Such persons may also file a written request for a hearing on the
application on or before January 5, 2022.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on August 25, 2021, Fisher Clinical Services, Inc.,
700A-C Nestle Way, Breinigsville, Pennsylvania 18031-1522, applied to
be registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract....................... 7350 I
Psilocybin.............................. 7437 I
Methylphenidate......................... 1724 II
Levorphanol............................. 9220 II
Noroxymorphone.......................... 9668 II
Tapentadol.............................. 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
use in clinical trials only. No other activity for these drug codes is
authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-26364 Filed 12-3-21; 8:45 am]
BILLING CODE 4410-09-P
